We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Buys

Rank Stock Value
1
INIO
INNIO N.V.
INIO
+$177M
2
AMD icon
Advanced Micro Devices
AMD
+$119M
3
FORM icon
FormFactor
FORM
+$101M
4
CBRS
Cerebras Systems
CBRS
+$70.1M
5
ONTO icon
Onto Innovation
ONTO
+$64.5M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVIR icon
551
Atea Pharmaceuticals
AVIR
$468M
$7.7K ﹤0.01%
1,656
-87
-5% -$433
NXRT
552
NexPoint Residential Trust
NXRT
$608M
$7.68K ﹤0.01%
275
-52
-16% -$1.45K
VNDA icon
553
Vanda Pharmaceuticals
VNDA
$328M
$7.55K ﹤0.01%
1,234
-93
-7% -$608
OABI icon
554
OmniAb
OABI
$630M
$7.31K ﹤0.01%
2,973
-228
-7% -$453
LXEO icon
555
Lexeo Therapeutics
LXEO
$401M
$7.19K ﹤0.01%
1,545
-83
-5% -$449
LRMR icon
556
Larimar Therapeutics
LRMR
$398M
$7.01K ﹤0.01%
2,300
+390
+20% +$1.55K
BFS
557
Saul Centers
BFS
$804M
$6.92K ﹤0.01%
185
-25
-12% -$873
KROS icon
558
Keros Therapeutics
KROS
$224M
$6.75K ﹤0.01%
631
-46
-7% -$512
IMRX icon
559
Immuneering
IMRX
$312M
$6.69K ﹤0.01%
1,341
-101
-7% -$511
AUTL
560
Autolus Therapeutics
AUTL
$596M
$6.65K ﹤0.01%
4,154
-319
-7% -$500
LYEL icon
561
Lyell Immunopharma
LYEL
$352M
$6.35K ﹤0.01%
452
-18
-4% -$326
TKNO icon
562
Alpha Teknova
TKNO
$372M
$6.31K ﹤0.01%
1,111
-83
-7% -$330
FHTX icon
563
Foghorn Therapeutics
FHTX
$292M
$6.06K ﹤0.01%
1,241
-22
-2% -$98
TRDA icon
564
Entrada Therapeutics
TRDA
$278M
$5.98K ﹤0.01%
812
-40
-5% -$384
NMRA icon
565
Neumora Therapeutics
NMRA
$246M
$5.9K ﹤0.01%
3,471
-266
-7% -$506
SIGA icon
566
SIGA Technologies
SIGA
$236M
$5.41K ﹤0.01%
1,487
-111
-7% -$497
AIV
567
Aimco
AIV
$372M
$5.23K ﹤0.01%
1,762
-309
-15% -$1.18K
IVVD icon
568
Invivyd
IVVD
$243M
$5.17K ﹤0.01%
5,929
-199
-3% -$249
FULC icon
569
Fulcrum Therapeutics
FULC
$294M
$5.16K ﹤0.01%
1,411
+207
+17% +$1.26K
AVXL icon
570
Anavex Life Sciences
AVXL
$265M
$5.09K ﹤0.01%
1,964
-30
-2% -$89
OBIO icon
571
Orchestra BioMed
OBIO
$305M
$5.06K ﹤0.01%
1,173
-87
-7% -$356
ACIU icon
572
AC Immune
ACIU
$284M
$4.96K ﹤0.01%
2,084
-158
-7% -$435
NBP
573
NovaBridge Biosciences American Depositary Shares
NBP
$208M
$4.63K ﹤0.01%
2,377
+56
+2% +$114
CHRS icon
574
Coherus Oncology
CHRS
$219M
$4.43K ﹤0.01%
3,164
+450
+17% +$735
VYGR icon
575
Voyager Therapeutics
VYGR
$216M
$4.36K ﹤0.01%
1,245
-94
-7% -$356
21 22
23
24 25

Similar funds

GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
MWM
Modern Wealth Management Lenexa, Kansas $8.4B AUM 21.02% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.